On the public citation graph
Venous thromboembolism in the elderly
0 signed · 181 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archinte.151.5.933openalex-snapshot
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study
inferredcites →https://doi.org/10.1001/archinte.156.4.409openalex-snapshot
Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators
inferredcites →https://doi.org/10.1001/archinte.156.8.857openalex-snapshot
Aging and Heparin-Related Bleeding
inferredcites →https://doi.org/10.1001/archinte.158.6.585openalex-snapshot
Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism
inferredcites →https://doi.org/10.1001/archinte.158.9.1005openalex-snapshot
Length of Hospital Stay for Treatment of Deep Venous Thrombosis and the Incidence of Recurrent Thromboembolism
inferredcites →https://doi.org/10.1001/archinte.159.5.457openalex-snapshot
Prediction of the Risk of Bleeding During Anticoagulant Treatment for Venous Thromboembolism
inferredcites →https://doi.org/10.1001/archinte.160.6.761openalex-snapshot
Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary Embolism
inferredcites →https://doi.org/10.1001/jama.293.6.681openalex-snapshot
Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis
inferredcites →https://doi.org/10.1016/0741-5214(92)90773-2openalex-snapshot
A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism
inferredcites →https://doi.org/10.1016/s0140-6736(00)02470-3openalex-snapshot
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison
inferredcites →https://doi.org/10.1055/s-0037-1615599openalex-snapshot
Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Risk of Bleeding
inferredcites →https://doi.org/10.1055/s-0037-1616243openalex-snapshot
The Epidemiology of Venous Thromboembolism in the Community
inferredcites →https://doi.org/10.1056/nejm196808082790603openalex-snapshot
Efficacy and Toxicity of Heparin in Relation to Age and Sex
inferredcites →https://doi.org/10.1056/nejm197208172870703openalex-snapshot
A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time
inferredcites →https://doi.org/10.1056/nejm199507063330102openalex-snapshot
Optimal Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Recent Cerebral Ischemia
inferredcites →https://doi.org/10.1056/nejmoa035422openalex-snapshot
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
inferredcites →https://doi.org/10.1111/j.1525-1497.2006.00458.xopenalex-snapshot
The worcester venous thromboembolism study
inferredcites →https://doi.org/10.1161/circulationaha.106.685974openalex-snapshot
Beyond Unfractionated Heparin and Warfarin
inferredcites →https://doi.org/10.7326/0003-4819-125-1-199607010-00001openalex-snapshot
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
inferredcites →https://doi.org/10.7326/0003-4819-140-11-200406010-00007openalex-snapshot
Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3951071openalex-extracted
Effect of Low- Power Laser Therapy with Aerobic Exercise on Anthropometric Measures and Selected Coagulation Biomarkers in Obese Older Adults: Randomized Controlled Trial
inferred← citeshttps://doi.org/10.1002/14651858.cd011468openalex-snapshot
Angioplasty for deep venous thrombosis
inferred← citeshttps://doi.org/10.1002/9781119484288.ch25openalex-snapshot
When to anticoagulate, and which anticoagulant?
inferred← citeshttps://doi.org/10.1002/9781119484288.ch37openalex-snapshot
Venous thromboembolism in the elderly
inferred← citeshttps://doi.org/10.1002/ags3.12256openalex-snapshot
Clinical analysis of preoperative deep vein thrombosis risk factors in patients with colorectal cancer: Retrospective observational study
inferred← citeshttps://doi.org/10.1002/jcph.5openalex-snapshot
The Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban—An Oral, Direct Factor Xa Inhibitor
inferred← citeshttps://doi.org/10.1007/978-1-4419-5792-4_17openalex-snapshot
Disease-Modifying Antirheumatic Drug Use in Older Rheumatoid Arthritis Patients
inferred← citeshttps://doi.org/10.1007/s00277-026-06920-6openalex-snapshot
Risk factors for venous thromboembolism in newly diagnosed multiple myeloma patients based on thrombosis prophylaxis
inferred← citeshttps://doi.org/10.1007/s00784-023-05317-3openalex-snapshot
Platelet-rich fibrin ensures hemostasis after single-tooth removal under factor Xa inhibitors — a clinical prospective randomized split-mouth study
inferred← citeshttps://doi.org/10.1007/s11136-014-0704-xopenalex-snapshot
The VEINES-QOL/Sym questionnaire is a reliable and valid disease-specific quality of life measure for deep vein thrombosis in elderly patients
inferred← citeshttps://doi.org/10.1007/s11239-011-0594-5openalex-snapshot
Standard or extended-duration prophylaxis in medical patients? A review of the evidence
inferred← citeshttps://doi.org/10.1007/s11239-013-0875-2openalex-snapshot
The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology
inferred← citeshttps://doi.org/10.1007/s11239-015-1214-6openalex-snapshot
Effectiveness and safety of thrombolytic therapy in elderly patients with pulmonary embolism
inferred← citeshttps://doi.org/10.1007/s11239-018-1665-7openalex-snapshot
Is acute pulmonary embolism more severe in the presence of obstructive sleep apnea? Results from an observational cohort study
inferred← citeshttps://doi.org/10.1007/s11239-018-1685-3openalex-snapshot
Impact of functional status on 6-month mortality in elderly patients with acute venous thromboembolism: results from a prospective cohort
inferred← citeshttps://doi.org/10.1007/s11239-019-01878-xopenalex-snapshot
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism
inferred← citeshttps://doi.org/10.1007/s11239-020-02239-9openalex-snapshot
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
inferred← citeshttps://doi.org/10.1007/s11239-020-02274-6openalex-snapshot
Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETE
inferred← citeshttps://doi.org/10.1007/s11239-021-02415-5openalex-snapshot
Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE)
inferred← citeshttps://doi.org/10.1007/s11239-021-02442-2openalex-snapshot
Venous thromboembolism in non-COVID-19 population during the pandemic: a nationwide multicenter retrospective survey
inferred← citeshttps://doi.org/10.1007/s11739-019-02216-yopenalex-snapshot
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study
inferred← citeshttps://doi.org/10.1007/s11739-020-02381-5openalex-snapshot
Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism
inferred← citeshttps://doi.org/10.1007/s11834-010-0011-yopenalex-snapshot
Connaître les particularités du traitement par antivitamine K chez le patient âgé ou comment minimiser leur iatrogénie ?
inferred← citeshttps://doi.org/10.1007/s12325-023-02717-5openalex-snapshot
Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study
inferred← citeshttps://doi.org/10.1007/s12612-011-0182-5openalex-snapshot
Gestion des accidents des anticoagulants chez le sujet âgé en médecine d’urgence
inferred← citeshttps://doi.org/10.1007/s13341-017-0726-4openalex-snapshot
Seuil des D-dimères ajusté à l’âge chez les patients de plus de 75 ans : une étude rétrospective
inferred← citeshttps://doi.org/10.1007/s40266-013-0101-0openalex-snapshot
Optimizing the Use of Anticoagulants (Heparins and Oral Anticoagulants) in the Elderly
inferred← citeshttps://doi.org/10.1007/s40266-013-0127-3openalex-snapshot
Use of Vitamin K Antagonist Therapy in Geriatrics: A French National Survey from the French Society of Geriatrics and Gerontology (SFGG)
inferred← citeshttps://doi.org/10.1007/s40520-018-1060-4openalex-snapshot
Permanent atrial fibrillation and pulmonary embolism in elderly patients without deep vein thrombosis: is there a relationship?
inferred← citeshttps://doi.org/10.1016/b978-0-323-54454-2.00005-4openalex-snapshot
Central Nervous System Disorders Affecting Mobility in Older Adults
inferred← citeshttps://doi.org/10.1016/b978-1-4377-0398-6.00077-9openalex-snapshot
Pulmonary Embolism
inferred← citeshttps://doi.org/10.1016/b978-84-8086-956-0.00077-0openalex-snapshot
10.1016/b978-84-8086-956-0.00077-0
inferred← citeshttps://doi.org/10.1016/j.amjmed.2014.02.011openalex-snapshot
Venous Thromboembolism in Older Adults: A Community-based Study
inferred← citeshttps://doi.org/10.1016/j.amjmed.2016.09.008openalex-snapshot
Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study
inferred← citeshttps://doi.org/10.1016/j.amjmed.2017.05.026openalex-snapshot
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
inferred← citeshttps://doi.org/10.1016/j.amjmed.2017.12.015openalex-snapshot
Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients
inferred← citeshttps://doi.org/10.1016/j.arbr.2019.09.009openalex-snapshot
Quality of Life After a Venous Thrombosis in Elderly Patients: Results From a Prospective Spanish Cohort
inferred← citeshttps://doi.org/10.1016/j.arbres.2019.09.018openalex-snapshot
Quality of Life After a Venous Thrombosis in Elderly Patients: Results From a Prospective Spanish Cohort
inferred← citeshttps://doi.org/10.1016/j.arbres.2023.12.016openalex-snapshot
Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry
inferred← citeshttps://doi.org/10.1016/j.avsg.2019.08.089openalex-snapshot
Prevalence and Risk Factors of Preoperative Deep Vein Thrombosis in Patients with End-Stage Knee Osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.avsg.2025.09.054openalex-snapshot
Comparison of Endovascular Therapy Versus Anticoagulation Alone for the Treatment of Subacute Iliofemoral Deep Vein Thrombosis in Elderly Patients: Measures of 2-Year Clinical Outcome and Quality of Life
inferred← citeshttps://doi.org/10.1016/j.crad.2012.09.010openalex-snapshot
CT pulmonary angiography in elderly patients: Outcomes in patients aged >85 years
inferred← citeshttps://doi.org/10.1016/j.ejim.2014.03.009openalex-snapshot
Diagnosis and management of pulmonary embolism in the elderly
inferred← citeshttps://doi.org/10.1016/j.ejim.2016.07.025openalex-snapshot
Venous thromboembolism in centenarians: Findings from the RIETE registry
inferred← citeshttps://doi.org/10.1016/j.ejim.2019.08.002openalex-snapshot
D-dimer levels enhance the discriminatory capacity of bleeding risk scores for predicting in-hospital bleeding events in acute pulmonary embolism
inferred← citeshttps://doi.org/10.1016/j.eprac.2020.11.001openalex-snapshot
Cardiovascular Health Maintenance in Aging Individuals: The Implications for Transgender Men and Women on Hormone Therapy
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e27415openalex-snapshot
Construction and validation of a perioperative concomitant lower extremity deep vein thrombosis line graph model in patients with aneurysmal subarachnoid hemorrhage
inferred← citeshttps://doi.org/10.1016/j.ijcard.2023.04.050openalex-snapshot
Age and long-term outcomes of patients with venous thromboembolism: From the COMMAND VTE Registry
inferred← citeshttps://doi.org/10.1016/j.jacc.2010.01.057openalex-snapshot
Risk Factors for Venous Thromboembolism
inferred← citeshttps://doi.org/10.1016/j.jacc.2015.12.028openalex-snapshot
Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism
inferred← citeshttps://doi.org/10.1016/j.jtha.2023.04.025openalex-snapshot
Prediction of very early major bleeding risk in acute pulmonary embolism: an independent external validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction (PE-SARD) bleeding score
inferred← citeshttps://doi.org/10.1016/j.jtha.2023.07.022openalex-snapshot
Quality of life in elderly patients with venous thromboembolism assessed using patient-reported outcome measures
inferred← citeshttps://doi.org/10.1016/j.jvs.2011.05.114openalex-snapshot
Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis
inferred← citeshttps://doi.org/10.1016/j.jvs.2017.02.052openalex-snapshot
Safety and efficacy of rivaroxaban compared with warfarin in patients undergoing peripheral arterial procedures
inferred← citeshttps://doi.org/10.1016/j.rdc.2006.12.011openalex-snapshot
Disease-Modifying Antirheumatic Drug Use in the Elderly Rheumatoid Arthritis Patient
inferred← citeshttps://doi.org/10.1016/j.thromres.2011.02.017openalex-snapshot
Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy
inferred← citeshttps://doi.org/10.1016/j.thromres.2011.03.002openalex-snapshot
Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: The Innohep® in Renal Insufficiency Study (IRIS)
inferred← citeshttps://doi.org/10.1016/j.thromres.2011.09.013openalex-snapshot
Use of anticoagulants in elderly patients
inferred← citeshttps://doi.org/10.1016/j.thromres.2014.03.038openalex-snapshot
Pharmacodynamics assessment of Bemiparin after multiple prophylactic and single therapeutic doses in adult and elderly healthy volunteers and in subjects with varying degrees of renal impairment
inferred← citeshttps://doi.org/10.1016/j.thromres.2014.05.013openalex-snapshot
Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: Efficacy and safety of non-VKA oral anticoagulants in selected populations
inferred← citeshttps://doi.org/10.1016/j.thromres.2015.05.010openalex-snapshot
Venous thromboembolism in patients with chronic lymphocytic leukemia
inferred← citeshttps://doi.org/10.1016/j.thromres.2015.06.021openalex-snapshot
Clinical analysis of preoperative deep vein thrombosis risk factors in patients undergoing total hip arthroplasty
inferred← citeshttps://doi.org/10.1016/j.thromres.2015.07.022openalex-snapshot
Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.thromres.2015.11.034openalex-snapshot
Association between smoking and recurrence of venous thromboembolism and bleeding in elderly patients with past acute venous thromboembolism
inferred← citeshttps://doi.org/10.1016/j.thromres.2017.05.015openalex-snapshot
Venous thromboembolism in the elderly: A narrative review
inferred← citeshttps://doi.org/10.1016/j.thromres.2019.02.017openalex-snapshot
Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism
inferred← citeshttps://doi.org/10.1016/j.thromres.2019.10.008openalex-snapshot
Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolism
inferred← citeshttps://doi.org/10.1016/j.thromres.2020.11.039openalex-snapshot
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population
inferred← citeshttps://doi.org/10.1016/j.thromres.2022.08.001openalex-snapshot
Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment
inferred← citeshttps://doi.org/10.1016/j.thromres.2025.109403openalex-snapshot
Efficacy and safety of anticoagulant treatment in elderly patients with venous thromboembolism beyond the first 3 to 6 months of therapy: A narrative review
inferred← citeshttps://doi.org/10.1038/s41598-019-55213-8openalex-snapshot
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
inferred← citeshttps://doi.org/10.1055/a-1174-1290openalex-snapshot
Management of Anticoagulant Treatment and Anticoagulation-Related Complications in Nonagenarians
inferred← citeshttps://doi.org/10.1055/s-0034-1384630openalex-snapshot
A Review of the Value of D-dimer Testing for Prediction of Recurrent Venous Thromboembolism with Increasing Age
inferred← citeshttps://doi.org/10.1055/s-0038-1657779openalex-snapshot
Hemostasis and Thrombosis in the Oldest Old
inferred← citeshttps://doi.org/10.1055/s-0038-1660436openalex-snapshot
Venous Thromboembolism (VTE) Incidence and VTE-Associated Survival among Olmsted County Residents of Local Nursing Homes
inferred← citeshttps://doi.org/10.1055/s-0038-1661392openalex-snapshot
Derivation and Validation of a Prediction Model for Risk Stratification of Post-Thrombotic Syndrome in Elderly Patients with a First Deep Vein Thrombosis
inferred← citeshttps://doi.org/10.1055/s-0041-1726345openalex-snapshot
Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism
inferred← citeshttps://doi.org/10.1055/s-0041-1740184openalex-snapshot
Do Patients with a Family or Personal History of Venous Thromboembolism have an Increased Risk of Recurrence?
inferred← citeshttps://doi.org/10.1055/s-0042-1760365openalex-snapshot
Bleeding Risk in Elderly Patients with Venous Thromboembolism Who Would Have Been Excluded from Anticoagulation Trials
inferred← citeshttps://doi.org/10.1080/02688697.2021.1968340openalex-snapshot
The effect of anti-thrombotics on the postoperative bleeding rate in patients undergoing craniotomy for brain tumor
inferred← citeshttps://doi.org/10.1080/03007995.2019.1653067openalex-snapshot
Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population
inferred← citeshttps://doi.org/10.1080/17474086.2018.1526667openalex-snapshot
The prevention of venous thromboembolism recurrence in the elderly: a still open issue
inferred← citeshttps://doi.org/10.1089/ars.2023.0365openalex-snapshot
Thrombosis and Aging: Fibrin Clot Properties and Oxidative Stress
inferred← citeshttps://doi.org/10.1093/aje/kwaf235openalex-snapshot
Comparative risk of nonvertebral fractures associated with oral anticoagulants in patients with venous thromboembolism
inferred← citeshttps://doi.org/10.1093/eurheartj/ehr392openalex-snapshot
Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss Venous ThromboEmbolism Registry (SWIVTER)
inferred← citeshttps://doi.org/10.1093/gerona/glq207openalex-snapshot
Obesity, Poor Muscle Strength, and Venous Thromboembolism in Older Persons: The InCHIANTI Study
inferred← citeshttps://doi.org/10.1093/gerona/glu240openalex-snapshot
Prevalence of Hereditary Thrombophilia in Patients Older Than 75 Years With Venous Thromboembolism Referred for Thrombophilia Screening
inferred← citeshttps://doi.org/10.1097/eja.0000000000000705openalex-snapshot
European guidelines on perioperative venous thromboembolism prophylaxis
inferred← citeshttps://doi.org/10.1097/mbc.0b013e3283566adbopenalex-snapshot
A new D-dimer cutoff in bedridden hospitalized elderly patients
inferred← citeshttps://doi.org/10.1097/mcp.0b013e32833a2356openalex-snapshot
Pulmonary embolism in patients over 90 years of age
inferred← citeshttps://doi.org/10.1097/md.0000000000015705openalex-snapshot
Efficacy of low-dose rivaroxaban in an 88-year-old female with pulmonary embolism
inferred← citeshttps://doi.org/10.1097/md.0000000000035329openalex-snapshot
Association between diabetes and venous thromboembolism: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1101/2025.04.03.25325187openalex-snapshot
Lecanemab and Anticoagulants: Projected Effects on Health and Quality of Life
inferred← citeshttps://doi.org/10.1111/cts.13433openalex-snapshot
Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism
inferred← citeshttps://doi.org/10.1111/j.1365-2796.2010.02254.xopenalex-snapshot
Contemporary management of pulmonary embolism: the answers to ten questions
inferred← citeshttps://doi.org/10.1111/j.1538-7836.2011.04458.xopenalex-snapshot
No accumulation of the peak anti‐factor Xa activity of tinzaparin in elderly patients with moderate‐to‐severe renal impairment: the IRIS substudy
inferred← citeshttps://doi.org/10.1111/jgs.12560openalex-snapshot
Unusual Case of Extensive Warfarin‐Induced Necrosis in an 84‐Year‐Old
inferred← citeshttps://doi.org/10.1111/jgs.13063openalex-snapshot
Acute Pulmonary Embolism in Individuals Aged 80 and Older
inferred← citeshttps://doi.org/10.1111/jgs.14279openalex-snapshot
Pathogenesis, Diagnosis, and Treatment of Venous Thromboembolism in Older Adults
inferred← citeshttps://doi.org/10.1111/joim.12236openalex-snapshot
Risk of falls and bleeding in elderly patients with acute venous thromboembolism
inferred← citeshttps://doi.org/10.1111/jth.12111openalex-snapshot
Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism
inferred← citeshttps://doi.org/10.1111/jth.14365openalex-snapshot
A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study
inferred← citeshttps://doi.org/10.1136/bmjopen-2016-012351openalex-snapshot
Towards the genetic basis of cerebral venous thrombosis—the BEAST Consortium: a study protocol
inferred← citeshttps://doi.org/10.1142/9781783267118_0002openalex-snapshot
Risk Assessment for Venous Thromboembolism
inferred← citeshttps://doi.org/10.1160/th-09-02-0104openalex-snapshot
Cardiovascular risk factors in idiopathic compared to riskassociated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP)
inferred← citeshttps://doi.org/10.1160/th-17-03-0162openalex-snapshot
Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation
inferred← citeshttps://doi.org/10.1160/th09-06-0346openalex-snapshot
Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years
inferred← citeshttps://doi.org/10.1160/th12-03-0209openalex-snapshot
Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor
inferred← citeshttps://doi.org/10.1160/th13-02-0170openalex-snapshot
Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients
inferred← citeshttps://doi.org/10.1160/th17-03-0176openalex-snapshot
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II
inferred← citeshttps://doi.org/10.1161/atvbaha.109.197145openalex-snapshot
Current Treatment of Venous Thromboembolism
inferred← citeshttps://doi.org/10.1161/atvbaha.110.203497openalex-snapshot
DVT: A New Era in Anticoagulant Therapy
inferred← citeshttps://doi.org/10.1177/00494755241287952openalex-snapshot
Clinical predictors of warfarin-associated bleeding: A case-control study
inferred← citeshttps://doi.org/10.1177/02683555241273064openalex-snapshot
Analysis of the efficacy of angiojet percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis versus catheter-directed thrombolysis alone in the treatment of subacute iliofemoral deep venous thrombosis in elderly patients
inferred← citeshttps://doi.org/10.1177/1074248420925021openalex-snapshot
Aspirin Is Associated With Reduced Rates of Venous Thromboembolism in Older Patients With Cancer
inferred← citeshttps://doi.org/10.1177/1076029611404218openalex-snapshot
The Impact of Age on the Delay in Diagnosis in Patients With Acute Pulmonary Embolism
inferred← citeshttps://doi.org/10.1177/1076029613493659openalex-snapshot
Hospitalizations of Adults ≥60 Years of Age With Venous Thromboembolism
inferred← citeshttps://doi.org/10.1177/10760296251333786openalex-snapshot
Multimorbidity and Venous Thromboembolism: Epidemiological Evidence, Pathophysiology, Prophylactic and Therapeutic Anticoagulation Efficacy, Safety, and Difficulties. A Review
inferred← citeshttps://doi.org/10.1177/10760296251396133openalex-snapshot
Optimizing Preoperative Venous Thromboembolism Risk Assessment in Elderly Hip Fracture Patients: A Refined Caprini Model Integrating D-Dimer and Injury-to-Admission Time
inferred← citeshttps://doi.org/10.1177/20503121241266360openalex-snapshot
In-hospital mortality and associated factors among patients admitted with venous thromboembolism at selected public hospitals of Harar Town, Eastern Ethiopia
inferred← citeshttps://doi.org/10.1182/blood-2019-01-846048openalex-snapshot
How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism
inferred← citeshttps://doi.org/10.1182/blood.2021010735openalex-snapshot
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia
inferred← citeshttps://doi.org/10.1182/bloodadvances.2022007263openalex-snapshot
Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
inferred← citeshttps://doi.org/10.1185/03007995.2014.915801openalex-snapshot
Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulants
inferred← citeshttps://doi.org/10.1186/1477-9560-12-6openalex-snapshot
Incidence of venous thromboembolism in northern Sweden (VEINS): a population-based study
inferred← citeshttps://doi.org/10.1186/s12890-023-02824-7openalex-snapshot
Clinical characteristics and mortality predictors among very old patients with pulmonary thromboembolism: a multicenter study report
inferred← citeshttps://doi.org/10.1186/s12959-015-0063-zopenalex-snapshot
Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
inferred← citeshttps://doi.org/10.1186/s12959-024-00645-0openalex-snapshot
Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods
inferred← citeshttps://doi.org/10.12687/phleb2315-4-2016openalex-snapshot
Venous thromboembolism in the elderly
inferred← citeshttps://doi.org/10.13055/ojcar_6_1_2.170529openalex-snapshot
Venous thromboembolic disease in Burkina Faso: results of the prospective registry REMAVET (registry of Venous Thromboembolic)
inferred← citeshttps://doi.org/10.1371/journal.pone.0100164openalex-snapshot
The Adherence to Initial Processes of Care in Elderly Patients with Acute Venous Thromboembolism
inferred← citeshttps://doi.org/10.1371/journal.pone.0148348openalex-snapshot
Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study
inferred← citeshttps://doi.org/10.1371/journal.pone.0184868openalex-snapshot
Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study
inferred← citeshttps://doi.org/10.1634/theoncologist.2011-0192openalex-snapshot
The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)
inferred← citeshttps://doi.org/10.17116/hirurgia2022061133openalex-snapshot
Features of the course and therapeutic aspects of deep vein thrombosis in elderly and senile patients
inferred← citeshttps://doi.org/10.2147/cia.s405075openalex-snapshot
Efficacy and Safety of Rivaroxaban for Extremely Aged Patients with Venous Thromboembolism: A Retrospective, Cross-Sectional Real-World Study
inferred← citeshttps://doi.org/10.2147/dhps.s601538openalex-snapshot
Trend of Reported Bleeding in Warfarin Compared with Direct Oral Anticoagulants in Japan
inferred← citeshttps://doi.org/10.2147/ijgm.s580403openalex-snapshot
Knowledge, Attitudes, and Practices Regarding Venous Thromboembolism Among Elderly Chinese Patients: A Cross-Sectional Study
inferred← citeshttps://doi.org/10.2147/vhrm.s264814openalex-snapshot
The Cumulative Incidence and Risk Factors of Recurrent Venous Thromboembolism in the Elderly
inferred← citeshttps://doi.org/10.2165/11586730-000000000-00000openalex-snapshot
Use of Low-Molecular-Weight Heparins and New Anticoagulants in Elderly Patients with Renal Impairment
inferred← citeshttps://doi.org/10.3109/00365513.2010.534173openalex-snapshot
A thrombin generation assay may reduce the need for compression ultrasonography for the exclusion of deep venous thrombosis in the elderly
inferred← citeshttps://doi.org/10.3390/ijms19051299openalex-snapshot
Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson’s Disease and Parkinsonism
inferred← citeshttps://doi.org/10.3390/ijms23052786openalex-snapshot
Addressing the Needs of the Rapidly Aging Society through the Development of Multifunctional Bioactive Coatings for Orthopedic Applications
inferred← citeshttps://doi.org/10.3390/jcdd12010015openalex-snapshot
Pulmonary Embolism in the Elderly: From Symptoms to Speckle Tracking Echocardiography
inferred← citeshttps://doi.org/10.3390/jcm12186050openalex-snapshot
Thrombin Generation Is Associated with Venous Thromboembolism Recurrence, but Not with Major Bleeding and Death in the Elderly: A Prospective Multicenter Cohort Study
inferred← citeshttps://doi.org/10.3390/molecules29204883openalex-snapshot
Overview of Venous Thromboembolism and Emerging Therapeutic Technologies Based on Nanocarriers-Mediated Drug Delivery Systems
inferred← citeshttps://doi.org/10.36150/2499-6564-437openalex-snapshot
Thromboembolic disease: a geriatric syndrome
inferred← citeshttps://doi.org/10.36660/abc.20201060openalex-snapshot
Terapia Trombolítica em Octogenários com Embolia Pulmonar Aguda
inferred← citeshttps://doi.org/10.37923/phle.2024.22.2.39openalex-snapshot
Direct Oral Anticoagulants in Fragile Patients with Venous Thromboembolism
inferred← citeshttps://doi.org/10.3810/hp.2014.10.1143openalex-snapshot
Treatment Patterns and Outcomes among Hospitalized Patients with Venous Thromboembolism in the United States: An Analysis of Electronic Health Records Data
inferred← citeshttps://doi.org/10.3892/etm.2020.8559openalex-snapshot
Current status of rivaroxaban in elderly patients with pulmonary embolism (Review)
inferred← citeshttps://doi.org/10.3892/etm.2020.8791openalex-snapshot
Rivaroxaban treatment for young patients with pulmonary embolism (Review)
inferred← citeshttps://doi.org/10.4055/cios24163openalex-snapshot
Incidence and Risk Factors of Deep Vein Thrombosis after Foot and Ankle Surgery
inferred← citeshttps://doi.org/10.4244/eij-d-23-00399openalex-snapshot
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty
inferred← citeshttps://doi.org/10.4321/s1886-36552012000100003openalex-snapshot
Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more
inferred← citeshttps://doi.org/10.5114/aoms/90673openalex-snapshot
Unprovoked pulmonary embolism in older adults: incidence and prognosis
inferred← citeshttps://doi.org/10.6084/m9.figshare.24979611openalex-snapshot
Additional file 1 of Clinical characteristics and mortality predictors among very old patients with pulmonary thromboembolism: a multicenter study report
inferred← citeshttps://doi.org/10.70675/967c8c75zdba6z435dzb6c8z45748547349eopenalex-snapshot
La maladie veineuse thromboembolique : étude des facteurs de risque de récidive
inferred← citeshttps://doi.org/10.7326/0003-4819-153-8-201010190-00009openalex-snapshot
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of d -Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.